Skip to main content

Labor Pain

1
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
1
EphedrinePhase 41 trial
Active Trials
NCT02062801Completed710Est. Oct 2013
DyAnsys
DyAnsysCA - San Mateo
1 program
ANSiStimN/A1 trial
Active Trials
NCT02427139Unknown50Est. Sep 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Sharp TherapeuticsEphedrine
DyAnsysANSiStim

Clinical Trials (2)

Total enrollment: 760 patients across 2 trials

Prophylactic Ephedrine and Combined Spinal Epidurals for Labor

Start: Jan 2012Est. completion: Oct 2013710 patients
Phase 4Completed

ANSiStim Study for Active Labor Pain

Start: Mar 2015Est. completion: Sep 201650 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.